| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.967 | 0.002 | 0.967 | Dopamine antagonist | 0.894 0.003 DBMET02984 0.602 0.004 DBMET02989 0.443 0.006 DBMET02995 0.741 0.004 DBMET02985 0.408 0.008 DBMET02990 0.212 0.018 DBMET02991 0.135 0.028 DBMET02992 | ||
| 0.961 | 0.002 | 0.961 | Dopamine D2 antagonist | 0.898 0.003 DBMET02984 0.584 0.004 DBMET02989 0.41 0.007 DBMET02995 0.731 0.004 DBMET02985 0.429 0.006 DBMET02990 0.221 0.015 DBMET02991 0.145 0.023 DBMET02992 | ||
| 0.961 | 0.002 | 0.981 | 5 Hydroxytryptamine antagonist | 0.981 0.002 DBMET02984 0.78 0.004 DBMET02989 0.131 0.059 DBMET02993 0.598 0.005 DBMET02995 0.119 0.065 DBMET02996 0.877 0.003 DBMET02985 0.848 0.003 DBMET02990 0.587 0.005 DBMET02991 0.344 0.015 DBMET02992 | DBMET02984 | |
| 0.958 | 0.002 | 0.974 | 5 Hydroxytryptamine 2 antagonist | 0.974 0.002 DBMET02984 0.736 0.004 DBMET02989 0.156 0.042 DBMET02993 0.576 0.005 DBMET02995 0.878 0.003 DBMET02985 0.787 0.003 DBMET02990 0.594 0.004 DBMET02991 0.442 0.008 DBMET02992 | DBMET02984 | |
| 0.938 | 0.002 | 0.967 | 5 Hydroxytryptamine 2A antagonist | 0.967 0.002 DBMET02984 0.665 0.003 DBMET02989 0.113 0.041 DBMET02993 0.535 0.004 DBMET02995 0.845 0.002 DBMET02985 0.719 0.003 DBMET02990 0.532 0.004 DBMET02991 0.422 0.006 DBMET02992 | DBMET02984 | |
| 0.921 | 0.002 | 0.921 | 5 Hydroxytryptamine 2C antagonist | 0.282 0.01 DBMET02984 0.704 0.003 DBMET02989 0.129 0.033 DBMET02993 0.448 0.005 DBMET02995 0.768 0.003 DBMET02985 0.129 0.033 DBMET02990 0.482 0.005 DBMET02991 0.261 0.011 DBMET02992 | ||
| 0.912 | 0.002 | 0.912 | 5 Hydroxytryptamine 2B antagonist | 0.351 0.011 DBMET02984 0.729 0.003 DBMET02989 0.139 0.046 DBMET02993 0.477 0.005 DBMET02995 0.77 0.003 DBMET02985 0.155 0.039 DBMET02990 0.528 0.005 DBMET02991 0.292 0.015 DBMET02992 | ||
| 0.903 | 0.002 | 0.927 | 5 Hydroxytryptamine 1A antagonist | 0.927 0.002 DBMET02984 0.627 0.004 DBMET02989 0.378 0.006 DBMET02995 0.739 0.003 DBMET02985 0.682 0.004 DBMET02990 0.399 0.006 DBMET02991 0.314 0.008 DBMET02992 | DBMET02984 | |
| 0.898 | 0.002 | 0.919 | 5 Hydroxytryptamine 1 antagonist | 0.919 0.002 DBMET02984 0.62 0.004 DBMET02989 0.431 0.005 DBMET02995 0.731 0.003 DBMET02985 0.675 0.004 DBMET02990 0.38 0.007 DBMET02991 0.288 0.011 DBMET02992 | DBMET02984 | |
| 0.895 | 0.003 | 0.895 | Dopamine D4 antagonist | 0.233 0.01 DBMET02984 0.186 0.014 DBMET02989 0.333 0.006 DBMET02995 0.423 0.005 DBMET02985 | ||
| 0.858 | 0.003 | 0.979 | 5 Hydroxytryptamine 1A agonist | 0.464 0.004 DBMET02984 0.979 0.002 DBMET02989 0.257 0.007 DBMET02995 0.579 0.004 DBMET02985 0.584 0.004 DBMET02990 0.738 0.003 DBMET02991 0.56 0.004 DBMET02992 | DBMET02989 | |
| 0.819 | 0.003 | 0.904 | Alpha adrenoreceptor antagonist | 0.904 0.003 DBMET02984 0.612 0.004 DBMET02989 0.401 0.009 DBMET02995 0.74 0.004 DBMET02985 0.757 0.004 DBMET02990 0.507 0.005 DBMET02991 0.28 0.017 DBMET02992 | DBMET02984 | |
| 0.799 | 0.003 | 0.885 | Alpha 1a adrenoreceptor antagonist | 0.885 0.002 DBMET02984 0.512 0.004 DBMET02989 0.363 0.007 DBMET02995 0.742 0.003 DBMET02985 0.647 0.004 DBMET02990 0.439 0.005 DBMET02991 0.285 0.01 DBMET02992 | DBMET02984 | |
| 0.791 | 0.003 | 0.884 | Alpha 1 adrenoreceptor antagonist | 0.884 0.002 DBMET02984 0.516 0.005 DBMET02989 0.375 0.008 DBMET02995 0.739 0.003 DBMET02985 0.667 0.004 DBMET02990 0.449 0.005 DBMET02991 0.285 0.012 DBMET02992 | DBMET02984 | |
| 0.773 | 0.002 | 0.846 | Alpha 1b adrenoreceptor antagonist | 0.846 0.002 DBMET02984 0.533 0.004 DBMET02989 0.062 0.059 DBMET02993 0.328 0.007 DBMET02995 0.761 0.002 DBMET02985 0.636 0.003 DBMET02990 0.516 0.004 DBMET02991 0.434 0.004 DBMET02992 | DBMET02984 | |
| 0.731 | 0.004 | 0.858 | 5 Hydroxytryptamine 1 agonist | 0.345 0.005 DBMET02984 0.858 0.003 DBMET02989 0.29 0.007 DBMET02995 0.445 0.005 DBMET02985 0.354 0.005 DBMET02990 0.521 0.004 DBMET02991 0.343 0.005 DBMET02992 | DBMET02989 | |
| 0.724 | 0.002 | 0.818 | Alpha 1d adrenoreceptor antagonist | 0.818 0.002 DBMET02984 0.503 0.004 DBMET02989 0.229 0.008 DBMET02995 0.709 0.003 DBMET02985 0.616 0.003 DBMET02990 0.061 0.04 DBMET02994 0.489 0.004 DBMET02991 0.429 0.004 DBMET02992 | DBMET02984 | |
| 0.672 | 0.005 | 0.696 | HERG channel blocker | 0.29 0.051 DBMET02984 0.696 0.005 DBMET02989 0.409 0.026 DBMET02993 0.587 0.009 DBMET02995 0.367 0.034 DBMET02985 0.424 0.024 DBMET02994 0.15 0.131 DBMET02991 | DBMET02989 | |
| 0.646 | 0.005 | 0.706 | Potassium channel (Voltage-sensitive) blocker | 0.28 0.056 DBMET02984 0.675 0.005 DBMET02989 0.377 0.031 DBMET02993 0.542 0.011 DBMET02995 0.667 0.005 DBMET02985 0.446 0.02 DBMET02994 0.706 0.005 DBMET02991 0.508 0.014 DBMET02992 | DBMET02991 | |
| 0.624 | 0.005 | 0.995 | Antiadrenergic | 0.943 0.003 DBMET02984 0.846 0.004 DBMET02989 0.337 0.011 DBMET02995 0.498 0.005 DBMET02985 0.995 0.002 DBMET02990 0.694 0.004 DBMET02991 0.469 0.006 DBMET02992 | DBMET02990 | |
| 0.623 | 0.005 | 0.995 | Adrenaline antagonist | 0.943 0.003 DBMET02984 0.846 0.004 DBMET02989 0.335 0.011 DBMET02995 0.496 0.005 DBMET02985 0.995 0.002 DBMET02990 0.694 0.004 DBMET02991 0.469 0.006 DBMET02992 | DBMET02990 | |
| 0.616 | 0.004 | 0.854 | 5 Hydroxytryptamine agonist | 0.247 0.011 DBMET02984 0.854 0.003 DBMET02989 0.46 0.005 DBMET02995 0.35 0.006 DBMET02985 0.409 0.005 DBMET02990 0.565 0.004 DBMET02991 0.222 0.012 DBMET02992 | DBMET02989 | |
| 0.611 | 0.004 | 0.745 | 5 Hydroxytryptamine 7 antagonist | 0.269 0.007 DBMET02984 0.745 0.003 DBMET02989 0.062 0.044 DBMET02993 0.377 0.005 DBMET02995 0.436 0.005 DBMET02985 0.247 0.008 DBMET02990 0.541 0.004 DBMET02991 0.22 0.01 DBMET02992 | DBMET02989 | |
| 0.525 | 0.004 | 0.648 | 5 Hydroxytryptamine 1F antagonist | 0.284 0.006 DBMET02984 0.648 0.003 DBMET02989 0.084 0.04 DBMET02993 0.338 0.005 DBMET02995 0.403 0.005 DBMET02985 0.411 0.005 DBMET02990 0.581 0.004 DBMET02991 0.425 0.005 DBMET02992 | DBMET02989 | |
| 0.468 | 0.014 | 0.59 | Potassium channel blocker | 0.155 0.131 DBMET02984 0.472 0.013 DBMET02989 0.225 0.078 DBMET02993 0.385 0.025 DBMET02995 0.543 0.008 DBMET02985 0.416 0.02 DBMET02994 0.59 0.005 DBMET02991 0.435 0.017 DBMET02992 | DBMET02991 | |
| 0.425 | 0.004 | 0.588 | Alpha 1 adrenoreceptor agonist | 0.081 0.023 DBMET02984 0.497 0.003 DBMET02989 0.136 0.011 DBMET02995 0.519 0.003 DBMET02985 0.1 0.017 DBMET02990 0.588 0.003 DBMET02991 0.299 0.004 DBMET02992 | DBMET02991 | |
| 0.417 | 0.004 | 0.417 | Dopamine D1 antagonist | 0.097 0.026 DBMET02984 0.256 0.008 DBMET02989 0.196 0.011 DBMET02995 0.162 0.013 DBMET02985 0.084 0.031 DBMET02991 | ||
| 0.371 | 0.005 | 0.371 | Dopamine D3 antagonist | 0.105 0.023 DBMET02984 0.121 0.02 DBMET02989 0.218 0.009 DBMET02995 0.165 0.013 DBMET02985 | ||
| 0.355 | 0.004 | 0.361 | 5 Hydroxytryptamine 1B antagonist | 0.109 0.02 DBMET02984 0.163 0.011 DBMET02989 0.361 0.004 DBMET02995 0.314 0.005 DBMET02985 0.133 0.015 DBMET02991 | DBMET02995 | |
| 0.34 | 0.003 | 0.34 | 5 Hydroxytryptamine 2A agonist | 0.103 0.013 DBMET02984 0.106 0.012 DBMET02986 0.249 0.004 DBMET02989 0.334 0.003 DBMET02995 0.105 0.013 DBMET02985 0.082 0.026 DBMET02990 0.084 0.024 DBMET02991 | ||
| 0.314 | 0.004 | 0.314 | 5 Hydroxytryptamine 1D antagonist | 0.097 0.024 DBMET02984 0.152 0.012 DBMET02989 0.31 0.004 DBMET02995 0.252 0.005 DBMET02985 0.116 0.018 DBMET02991 | ||
| 0.313 | 0.005 | 0.498 | Alpha adrenoreceptor agonist | 0.068 0.047 DBMET02984 0.425 0.004 DBMET02989 0.188 0.01 DBMET02995 0.364 0.004 DBMET02985 0.114 0.023 DBMET02990 0.498 0.003 DBMET02991 0.204 0.008 DBMET02992 | DBMET02991 | |
| 0.309 | 0.006 | 0.365 | Alpha 2a adrenoreceptor antagonist | 0.106 0.034 DBMET02984 0.242 0.01 DBMET02989 0.365 0.005 DBMET02995 0.217 0.012 DBMET02985 0.08 0.049 DBMET02990 0.173 0.018 DBMET02991 0.066 0.063 DBMET02992 | DBMET02995 | |
| 0.358 | 0.086 | 0.574 | MAP kinase kinase 6 inhibitor | 0.574 0.008 DBMET02989 0.259 0.179 DBMET02990 0.304 0.132 DBMET02991 0.311 0.125 DBMET02992 | DBMET02989 | |
| 0.249 | 0.007 | 0.249 | Sigma receptor antagonist | 0.049 0.035 DBMET02984 0.195 0.009 DBMET02989 0.044 0.038 DBMET02993 0.131 0.013 DBMET02995 0.063 0.026 DBMET02985 | ||
| 0.25 | 0.032 | 0.34 | MAP kinase kinase 3 inhibitor | 0.34 0.004 DBMET02989 0.193 0.144 DBMET02990 0.203 0.114 DBMET02991 0.218 0.078 DBMET02992 | DBMET02989 | |
| 0.236 | 0.029 | 0.257 | Acetylcholine M1 receptor antagonist | 0.118 0.111 DBMET02984 0.239 0.028 DBMET02989 0.257 0.023 DBMET02995 0.179 0.052 DBMET02985 0.12 0.109 DBMET02990 0.182 0.051 DBMET02991 | DBMET02995 | |
| 0.204 | 0.014 | 0.204 | Histamine H1 receptor antagonist | 0.105 0.038 DBMET02989 0.167 0.02 DBMET02995 0.097 0.043 DBMET02985 | ||
| 0.188 | 0.012 | 0.357 | 5 Hydroxytryptamine uptake inhibitor | 0.054 0.052 DBMET02984 0.357 0.005 DBMET02989 0.209 0.01 DBMET02995 0.091 0.03 DBMET02985 0.055 0.051 DBMET02990 0.128 0.019 DBMET02991 | DBMET02989 | |
| 0.302 | 0.14 | 0.365 | Analgesic | 0.229 0.204 DBMET02986 0.365 0.101 DBMET02995 | DBMET02995 | |
| 0.178 | 0.021 | 0.252 | Alpha 2 adrenoreceptor antagonist | 0.197 0.018 DBMET02989 0.252 0.011 DBMET02995 0.135 0.032 DBMET02985 0.08 0.066 DBMET02990 0.15 0.027 DBMET02991 | DBMET02995 | |
| 0.163 | 0.013 | 0.294 | Dopamine agonist | 0.096 0.029 DBMET02984 0.068 0.045 DBMET02986 0.294 0.005 DBMET02995 0.107 0.025 DBMET02985 | DBMET02995 | |
| 0.175 | 0.03 | 0.422 | Alpha 2b adrenoreceptor antagonist | 0.123 0.056 DBMET02984 0.107 0.069 DBMET02989 0.126 0.054 DBMET02993 0.422 0.005 DBMET02995 0.19 0.026 DBMET02985 0.132 0.049 DBMET02994 0.117 0.061 DBMET02991 | DBMET02995 | |
| 0.198 | 0.062 | 0.457 | Sigma receptor agonist | 0.154 0.083 DBMET02984 0.293 0.04 DBMET02993 0.457 0.014 DBMET02995 0.13 0.103 DBMET02996 0.154 0.083 DBMET02985 0.23 0.053 DBMET02994 | DBMET02995 | |
| 0.143 | 0.009 | 0.316 | DNA gyrase inhibitor | 0.316 0.004 DBMET02989 0.068 0.038 DBMET02990 0.072 0.034 DBMET02991 | DBMET02989 | |
| 0.139 | 0.007 | 0.185 | Dopamine D2 agonist | 0.077 0.015 DBMET02984 0.051 0.026 DBMET02986 0.185 0.005 DBMET02995 0.042 0.033 DBMET02996 0.081 0.014 DBMET02985 | DBMET02995 | |
| 0.165 | 0.063 | 0.248 | Hexokinase inhibitor | 0.127 0.109 DBMET02986 0.248 0.017 DBMET02989 0.146 0.084 DBMET02990 0.178 0.051 DBMET02991 0.154 0.074 DBMET02992 | DBMET02989 | |
| 0.109 | 0.008 | 0.213 | 5 Hydroxytryptamine 2 agonist | 0.048 0.041 DBMET02984 0.129 0.006 DBMET02989 0.213 0.004 DBMET02995 0.052 0.036 DBMET02985 0.056 0.031 DBMET02990 0.059 0.027 DBMET02991 | DBMET02995 | |
| 0.104 | 0.006 | 0.288 | Sigma 1 receptor antagonist | 0.288 0.004 DBMET02989 | DBMET02989 | |
| 0.226 | 0.129 | 0.386 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.2 0.157 DBMET02984 0.193 0.166 DBMET02993 0.386 0.024 DBMET02995 0.227 0.129 DBMET02996 0.222 0.133 DBMET02985 | DBMET02995 | |
| 0.148 | 0.052 | 0.38 | Glutamate receptor antagonist | 0.38 0.005 DBMET02986 0.153 0.049 DBMET02993 0.261 0.014 DBMET02995 0.102 0.094 DBMET02985 0.121 0.073 DBMET02994 | DBMET02986 | |
| 0.132 | 0.037 | 0.168 | Multidrug resistance-associated protein 1 inhibitor | 0.119 0.049 DBMET02984 0.099 0.08 DBMET02993 0.168 0.018 DBMET02995 0.122 0.046 DBMET02985 0.116 0.053 DBMET02994 | DBMET02995 | |
| 0.107 | 0.013 | 0.184 | 5 Hydroxytryptamine 6 antagonist | 0.063 0.034 DBMET02984 0.184 0.004 DBMET02989 0.084 0.021 DBMET02995 0.089 0.019 DBMET02985 0.122 0.01 DBMET02990 0.158 0.005 DBMET02991 0.063 0.034 DBMET02992 | DBMET02989 | |
| 0.181 | 0.093 | 0.189 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.149 0.129 DBMET02989 0.189 0.085 DBMET02995 | DBMET02995 | |
| 0.139 | 0.051 | 0.174 | Acetylcholine muscarinic antagonist | 0.154 0.041 DBMET02989 0.174 0.033 DBMET02995 | DBMET02995 | |
| 0.129 | 0.042 | 0.196 | AMP-activated protein kinase stimulant | 0.196 0.011 DBMET02986 0.129 0.042 DBMET02989 | DBMET02986 | |
| 0.13 | 0.043 | 0.286 | Alpha 2c adrenoreceptor antagonist | 0.086 0.08 DBMET02984 0.094 0.072 DBMET02989 0.286 0.007 DBMET02995 0.122 0.048 DBMET02985 0.086 0.08 DBMET02991 | DBMET02995 | |
| 0.11 | 0.024 | 0.236 | Cyclin B3 inhibitor | 0.094 0.031 DBMET02984 0.208 0.005 DBMET02986 0.131 0.018 DBMET02993 0.236 0.004 DBMET02995 0.107 0.025 DBMET02996 0.101 0.028 DBMET02985 0.082 0.037 DBMET02994 | DBMET02995 | |
| 0.098 | 0.018 | 0.135 | Acetylcholine M5 receptor antagonist | 0.073 0.029 DBMET02989 0.135 0.01 DBMET02995 0.068 0.033 DBMET02985 0.055 0.05 DBMET02991 | DBMET02995 | |
| 0.11 | 0.041 | 0.249 | Acetylcholine agonist | 0.249 0.009 DBMET02989 0.098 0.048 DBMET02995 | DBMET02989 | |
| 0.133 | 0.075 | 0.193 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.193 0.048 DBMET02995 | DBMET02995 | |
| 0.108 | 0.049 | 0.113 | Antihistaminic | 0.106 0.05 DBMET02989 0.113 0.046 DBMET02995 | DBMET02995 | |
| 0.08 | 0.025 | 0.657 | NMDA 2C receptor antagonist | 0.058 0.048 DBMET02984 0.657 0.002 DBMET02986 0.057 0.05 DBMET02993 0.494 0.003 DBMET02995 0.056 0.051 DBMET02996 0.058 0.048 DBMET02985 0.056 0.052 DBMET02994 | DBMET02986 | |
| 0.091 | 0.036 | 0.14 | Acetylcholine M4 receptor antagonist | 0.093 0.034 DBMET02989 0.14 0.012 DBMET02995 0.094 0.033 DBMET02985 0.065 0.064 DBMET02990 0.097 0.031 DBMET02991 | DBMET02995 | |
| 0.099 | 0.048 | 0.103 | Histamine antagonist | 0.098 0.049 DBMET02989 0.103 0.046 DBMET02995 | DBMET02995 | |
| 0.06 | 0.028 | 0.081 | Acetylcholine M2 receptor agonist | 0.081 0.013 DBMET02989 0.051 0.041 DBMET02995 0.054 0.036 DBMET02990 0.055 0.035 DBMET02991 | DBMET02989 | |
| 0.182 | 0.152 | 0.314 | 5 Hydroxytryptamine 1E antagonist | 0.212 0.117 DBMET02989 0.214 0.115 DBMET02993 0.314 0.022 DBMET02995 0.2 0.13 DBMET02985 0.192 0.14 DBMET02990 0.228 0.099 DBMET02991 | DBMET02995 | |
| 0.059 | 0.033 | 0.203 | 5 Hydroxytryptamine 7 agonist | 0.052 0.049 DBMET02993 0.203 0.004 DBMET02995 | DBMET02995 | |
| 0.049 | 0.023 | 0.049 | Antidiuretic hormone antagonist | 0.041 0.027 DBMET02995 | ||
| 0.083 | 0.057 | 0.153 | Acetylcholine M3 receptor agonist | 0.073 0.068 DBMET02984 0.081 0.059 DBMET02986 0.153 0.018 DBMET02995 0.076 0.065 DBMET02985 | DBMET02995 | |
| 0.081 | 0.056 | 0.123 | Adrenaline agonist | 0.097 0.039 DBMET02986 0.097 0.039 DBMET02989 0.085 0.051 DBMET02993 0.122 0.024 DBMET02995 0.102 0.035 DBMET02985 0.085 0.052 DBMET02994 0.123 0.024 DBMET02991 0.076 0.063 DBMET02992 | DBMET02991 | |
| 0.04 | 0.017 | 0.04 | Vasopressin 1 antagonist | 0.028 0.027 DBMET02989 0.028 0.027 DBMET02995 | ||
| 0.073 | 0.051 | 0.1 | Lipase inhibitor | 0.1 0.027 DBMET02989 | DBMET02989 | |
| 0.054 | 0.033 | 0.094 | Factor IXa inhibitor | 0.094 0.011 DBMET02989 | DBMET02989 | |
| 0.041 | 0.021 | 0.16 | DNA gyrase subunit B inhibitor | 0.16 0.004 DBMET02989 | DBMET02989 | |
| 0.044 | 0.024 | 0.106 | Dopamine D3 agonist | 0.037 0.031 DBMET02984 0.106 0.006 DBMET02995 0.042 0.025 DBMET02996 0.039 0.029 DBMET02985 | DBMET02995 | |
| 0.036 | 0.017 | 0.083 | Acetylcholine M4 receptor agonist | 0.083 0.005 DBMET02989 0.04 0.015 DBMET02995 | DBMET02989 | |
| 0.062 | 0.043 | 0.156 | Adrenaline uptake inhibitor | 0.156 0.009 DBMET02989 0.077 0.029 DBMET02995 0.075 0.031 DBMET02991 | DBMET02989 | |
| 0.035 | 0.017 | 0.035 | Vasopressin 1A antagonist | 0.031 0.018 DBMET02989 | ||
| 0.038 | 0.025 | 0.05 | Glucose-6-phosphate dehydrogenase inhibitor | 0.05 0.012 DBMET02989 | DBMET02989 | |
| 0.078 | 0.066 | 0.109 | Caspase 7 inhibitor | 0.096 0.033 DBMET02989 0.109 0.02 DBMET02995 0.077 0.069 DBMET02991 | DBMET02995 | |
| 0.049 | 0.037 | 0.132 | Dopamine D4 agonist | 0.132 0.01 DBMET02995 0.045 0.042 DBMET02985 | DBMET02995 | |
| 0.054 | 0.043 | 0.099 | 5 Hydroxytryptamine 3 antagonist | 0.091 0.02 DBMET02989 0.099 0.018 DBMET02995 | DBMET02995 | |
| 0.101 | 0.091 | 0.166 | Acetylcholine antagonist | 0.148 0.051 DBMET02989 0.166 0.042 DBMET02995 | DBMET02995 | |
| 0.052 | 0.044 | 0.119 | Cyclin B2 inhibitor | 0.095 0.01 DBMET02986 0.062 0.03 DBMET02993 0.119 0.006 DBMET02995 0.056 0.037 DBMET02996 0.05 0.047 DBMET02985 0.08 0.015 DBMET02994 | DBMET02995 | |
| 0.101 | 0.094 | 0.167 | Cholinergic antagonist | 0.15 0.052 DBMET02989 0.167 0.044 DBMET02995 | DBMET02995 | |
| 0.043 | 0.038 | 0.061 | Melanocortin antagonist | 0.045 0.036 DBMET02986 0.061 0.02 DBMET02995 | DBMET02995 | |
| 0.193 | 0.188 | 0.285 | Apoptosis antagonist | 0.285 0.096 DBMET02986 0.203 0.175 DBMET02995 | DBMET02986 | |
| 0.06 | 0.056 | 0.115 | 5 Hydroxytryptamine 3A antagonist | 0.115 0.01 DBMET02989 0.091 0.022 DBMET02995 0.066 0.048 DBMET02991 | DBMET02989 | |
| 0.053 | 0.053 | 0.122 | Cyclin B1 inhibitor | 0.091 0.015 DBMET02986 0.064 0.039 DBMET02993 0.122 0.007 DBMET02995 0.056 0.048 DBMET02996 0.083 0.019 DBMET02994 | DBMET02995 | |
| 0.108 | 0.108 | 0.495 | Interleukin 1 antagonist | 0.163 0.05 DBMET02989 0.495 0.005 DBMET02994 | DBMET02994 | |
| 0.061 | 0.061 | 0.442 | NMDA 2 receptor antagonist | 0.38 0.004 DBMET02986 0.433 0.004 DBMET02993 0.442 0.004 DBMET02995 0.368 0.004 DBMET02994 | DBMET02995 | |
| 0.047 | 0.049 | 0.096 | 5 Hydroxytryptamine 1B agonist | 0.096 0.008 DBMET02995 | DBMET02995 | |
| 0.046 | 0.049 | 0.153 | Acetylcholine muscarinic agonist | 0.153 0.01 DBMET02989 0.05 0.043 DBMET02995 | DBMET02989 | |
| 0.035 | 0.043 | 0.155 | 5 Hydroxytryptamine 2C agonist | 0.141 0.005 DBMET02989 0.155 0.005 DBMET02995 0.103 0.007 DBMET02990 0.11 0.007 DBMET02991 | DBMET02995 | |
| 0.019 | 0.029 | 0.034 | Melanocortin 5 antagonist | 0.034 0.014 DBMET02995 | DBMET02995 | |
| 0.032 | 0.044 | 0.055 | Melanocortin 4 antagonist | 0.039 0.032 DBMET02986 0.055 0.021 DBMET02995 | DBMET02995 | |
| 0.026 | 0.039 | 0.031 | Potassium channel (Inward rectifier) 1 blocker | 0.029 0.024 DBMET02985 0.029 0.025 DBMET02991 0.031 0.017 DBMET02992 | DBMET02992 | |
| 0.044 | 0.057 | 0.113 | Cyclin B inhibitor | 0.082 0.014 DBMET02986 0.051 0.044 DBMET02993 0.113 0.008 DBMET02995 0.068 0.023 DBMET02994 | DBMET02995 | |
| 0.085 | 0.104 | 0.339 | Interleukin 1b antagonist | 0.149 0.041 DBMET02989 0.339 0.007 DBMET02994 | DBMET02994 | |
| 0.03 | 0.05 | 0.145 | Acetylcholine M1 receptor agonist | 0.145 0.008 DBMET02989 | DBMET02989 | |
| 0.132 | 0.153 | 0.573 | Anticonvulsant | 0.516 0.011 DBMET02986 0.573 0.008 DBMET02995 0.164 0.113 DBMET02985 | DBMET02995 | |
| 0.063 | 0.093 | 0.689 | NMDA receptor antagonist | 0.689 0.003 DBMET02986 0.291 0.007 DBMET02993 0.464 0.004 DBMET02995 0.087 0.057 DBMET02985 0.353 0.005 DBMET02994 | DBMET02986 | |
| 0.011 | 0.041 | 0.042 | Dopamine autoreceptor agonist | 0.042 0.009 DBMET02995 | DBMET02995 | |
| 0.027 | 0.058 | 0.071 | CDK5/p25 inhibitor | 0.042 0.028 DBMET02986 0.071 0.011 DBMET02995 | DBMET02995 | |
| 0.02 | 0.061 | 0.043 | 5 Hydroxytryptamine 3B antagonist | 0.043 0.019 DBMET02989 0.043 0.019 DBMET02995 | DBMET02995 | |
| 0.011 | 0.054 | 0.064 | Nociceptin (N/OFQ) receptor antagonist | 0.038 0.022 DBMET02986 0.064 0.009 DBMET02995 | DBMET02995 | |
| 0.035 | 0.08 | 0.08 | Nicotinic alpha7 receptor agonist | 0.08 0.018 DBMET02989 | DBMET02989 | |
| 0.135 | 0.18 | 0.223 | Spasmolytic | 0.165 0.149 DBMET02989 0.223 0.104 DBMET02995 | DBMET02995 | |
| 0.033 | 0.079 | 0.098 | Nicotinic neuronal receptor agonist | 0.098 0.013 DBMET02989 0.061 0.035 DBMET02995 | DBMET02989 | |
| 0.097 | 0.144 | 0.131 | Cholinergic | 0.131 0.094 DBMET02995 | DBMET02995 | |
| 0.054 | 0.102 | 0.154 | Acetylcholine nicotinic agonist | 0.154 0.016 DBMET02989 0.093 0.043 DBMET02995 | DBMET02989 | |
| 0.027 | 0.076 | 0.086 | 5 Hydroxytryptamine 2B agonist | 0.04 0.024 DBMET02986 0.048 0.015 DBMET02989 0.086 0.005 DBMET02995 0.04 0.025 DBMET02990 0.044 0.019 DBMET02991 | DBMET02995 | |
| 0.245 | 0.296 | 0.427 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.346 0.155 DBMET02986 0.371 0.128 DBMET02989 0.427 0.078 DBMET02995 0.316 0.192 DBMET02990 0.316 0.192 DBMET02991 0.323 0.182 DBMET02992 | DBMET02995 | |
| 0.022 | 0.075 | 0.073 | p53 inhibitor | 0.073 0.005 DBMET02986 0.043 0.018 DBMET02995 | DBMET02986 | |
| 0.008 | 0.062 | 0.028 | Kainate receptor 3 antagonist | 0.028 0.005 DBMET02986 0.017 0.012 DBMET02995 | DBMET02986 | |
| 0.01 | 0.065 | 0.056 | Kainate receptor 4 antagonist | 0.056 0.006 DBMET02986 0.031 0.013 DBMET02995 | DBMET02986 | |
| 0.011 | 0.068 | 0.024 | Bombesin agonist | 0.024 0.013 DBMET02989 | DBMET02989 | |
| 0.01 | 0.068 | 0.02 | Bombesin 3 receptor agonist | 0.02 0.011 DBMET02989 | DBMET02989 | |
| 0.136 | 0.194 | 0.359 | Cardiotonic | 0.268 0.071 DBMET02986 0.359 0.037 DBMET02995 0.192 0.127 DBMET02994 | DBMET02995 | |
| 0.014 | 0.074 | 0.296 | Kainate receptor 2 antagonist | 0.296 0.002 DBMET02986 0.125 0.004 DBMET02995 | DBMET02986 | |
| 0.021 | 0.085 | 0.272 | NMDA 2A receptor antagonist | 0.272 0.004 DBMET02986 0.146 0.007 DBMET02993 0.258 0.004 DBMET02995 0.12 0.009 DBMET02994 | DBMET02986 | |
| 0.027 | 0.092 | 0.048 | Poly(ADP-ribose) polymerase inhibitor | 0.048 0.026 DBMET02995 | DBMET02995 | |
| 0.112 | 0.18 | 0.162 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.162 0.101 DBMET02995 | DBMET02995 | |
| 0.153 | 0.223 | 0.287 | Transcription factor NF kappa B inhibitor | 0.287 0.102 DBMET02986 0.273 0.111 DBMET02989 | DBMET02986 | |
| 0.024 | 0.095 | 0.265 | AMPA 4 receptor antagonist | 0.265 0.003 DBMET02986 0.055 0.012 DBMET02995 | DBMET02986 | |
| 0.041 | 0.113 | 0.16 | 5 Hydroxytryptamine 5A antagonist | 0.16 0.007 DBMET02995 | DBMET02995 | |
| 0.011 | 0.083 | 0.029 | Dipeptidyl peptidase I inhibitor | 0.029 0.023 DBMET02995 | DBMET02995 | |
| 0.055 | 0.128 | 0.127 | Urease inhibitor | 0.127 0.038 DBMET02989 | DBMET02989 | |
| 0.025 | 0.098 | 0.043 | Nerve growth factor antagonist | 0.043 0.03 DBMET02995 | DBMET02995 | |
| 0.009 | 0.084 | 0.018 | Factor IX inhibitor | 0.018 0.013 DBMET02986 | DBMET02986 | |
| 0.074 | 0.15 | 0.134 | Ribosomal protein S6 kinase inhibitor | 0.134 0.078 DBMET02989 | DBMET02989 | |
| 0.032 | 0.109 | 0.182 | Potassium channel Kv1.5 blocker | 0.124 0.012 DBMET02985 0.182 0.005 DBMET02991 0.132 0.01 DBMET02992 | DBMET02991 | |
| 0.003 | 0.081 | 0.011 | Melatonin 5 antagonist | 0.011 0.009 DBMET02995 | DBMET02995 | |
| 0.066 | 0.146 | 0.097 | Nav1.1 sodium channel blocker | 0.097 0.07 DBMET02993 0.09 0.08 DBMET02995 | DBMET02993 | |
| 0.017 | 0.099 | 0.04 | Melanocortin 1 antagonist | 0.04 0.024 DBMET02995 | DBMET02995 | |
| 0.026 | 0.109 | 0.076 | Acetylcholine M2 receptor antagonist | 0.076 0.032 DBMET02995 | DBMET02995 | |
| 0.018 | 0.102 | 0.034 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.034 0.032 DBMET02995 | DBMET02995 | |
| 0.028 | 0.112 | 0.043 | DNA gyrase subunit A inhibitor | 0.043 0.027 DBMET02989 | DBMET02989 | |
| 0.036 | 0.121 | 0.152 | 5 Hydroxytryptamine 5 antagonist | 0.152 0.007 DBMET02995 | DBMET02995 | |
| 0.036 | 0.122 | 0.086 | Check point kinase 1 inhibitor | 0.086 0.035 DBMET02995 | DBMET02995 | |
| 0.018 | 0.108 | 0.096 | Neurokinin 2 antagonist | 0.038 0.032 DBMET02995 0.096 0.011 DBMET02994 | DBMET02994 | |
| 0.024 | 0.114 | 0.044 | Phenylethanolamine N methyltransferase inhibitor | 0.044 0.022 DBMET02989 0.041 0.028 DBMET02995 0.038 0.033 DBMET02990 0.043 0.023 DBMET02991 | DBMET02989 | |
| 0.021 | 0.112 | 0.456 | NMDA receptor subunit 3B antagonist | 0.456 0.003 DBMET02986 0.167 0.005 DBMET02995 | DBMET02986 | |
| 0.172 | 0.264 | 0.259 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.259 0.055 DBMET02989 0.209 0.142 DBMET02990 0.219 0.117 DBMET02991 0.212 0.134 DBMET02992 | DBMET02989 | |
| 0.007 | 0.105 | 0.042 | Kainate receptor 5 antagonist | 0.042 0.006 DBMET02986 | DBMET02986 | |
| 0.053 | 0.154 | 0.189 | Polo-like kinase-4 inhibitor | 0.105 0.071 DBMET02995 0.189 0.018 DBMET02992 | DBMET02992 | |
| 0.026 | 0.126 | 0.076 | Dopamine uptake inhibitor | 0.076 0.027 DBMET02995 | DBMET02995 | |
| 0.021 | 0.122 | 0.041 | Acid-sensing ion channel blocker | 0.041 0.027 DBMET02995 | DBMET02995 | |
| 0.028 | 0.136 | 0.062 | Histamine H4 receptor antagonist | 0.047 0.036 DBMET02989 0.062 0.017 DBMET02995 | DBMET02995 | |
| 0.035 | 0.144 | 0.101 | CXC chemokine receptor antagonist | 0.065 0.057 DBMET02986 0.101 0.024 DBMET02995 | DBMET02995 | |
| 0.034 | 0.143 | 0.083 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.083 0.048 DBMET02995 | DBMET02995 | |
| 0.07 | 0.183 | 0.178 | NADPH oxidase inhibitor | 0.178 0.041 DBMET02986 0.105 0.104 DBMET02989 0.152 0.053 DBMET02995 | DBMET02986 | |
| 0.024 | 0.138 | 0.07 | H+/K+-transporting ATPase inhibitor | 0.07 0.017 DBMET02989 0.048 0.04 DBMET02994 | DBMET02989 | |
| 0.012 | 0.127 | 0.042 | Neurokinin 3 antagonist | 0.042 0.034 DBMET02994 | DBMET02994 | |
| 0.053 | 0.168 | 0.109 | Insulin receptor antagonist | 0.109 0.051 DBMET02995 | DBMET02995 | |
| 0.01 | 0.132 | 0.105 | AMPA receptor agonist | 0.04 0.017 DBMET02989 0.047 0.011 DBMET02985 0.036 0.023 DBMET02990 0.105 0.003 DBMET02991 0.077 0.004 DBMET02992 | DBMET02991 | |
| 0.026 | 0.149 | 0.057 | NMDA 2B receptor antagonist | 0.05 0.043 DBMET02993 0.057 0.034 DBMET02995 0.049 0.044 DBMET02994 | DBMET02995 | |
| 0.022 | 0.147 | 0.043 | Histamine H1 receptor agonist | 0.043 0.031 DBMET02989 0.043 0.033 DBMET02995 | DBMET02995 | |
| 0.083 | 0.212 | 0.186 | Cyclin-dependent kinase 8 inhibitor | 0.186 0.046 DBMET02989 0.128 0.106 DBMET02992 | DBMET02989 | |
| 0.129 | 0.26 | 0.179 | ErbB-1 antagonist | 0.179 0.117 DBMET02995 | DBMET02995 | |
| 0.045 | 0.177 | 0.144 | Cyclin-dependent kinase 5 inhibitor | 0.144 0.044 DBMET02986 0.119 0.059 DBMET02995 | DBMET02986 | |
| 0.045 | 0.178 | 0.238 | M18 aspartyl aminopeptidase inhibitor | 0.238 0.023 DBMET02989 | DBMET02989 | |
| 0.04 | 0.174 | 0.171 | Glycine receptor antagonist | 0.171 0.005 DBMET02986 0.139 0.01 DBMET02995 | DBMET02986 | |
| 0.054 | 0.19 | 0.504 | Cyclin-dependent kinase inhibitor | 0.504 0.007 DBMET02996 | DBMET02996 | |
| 0.008 | 0.145 | 0.089 | AMPA 2 receptor antagonist | 0.089 0.006 DBMET02986 | DBMET02986 | |
| 0.019 | 0.157 | 0.087 | Acetylcholine M3 receptor antagonist | 0.087 0.023 DBMET02995 | DBMET02995 | |
| 0.034 | 0.173 | 0.887 | Cyclin-dependent kinase 1 inhibitor | 0.151 0.041 DBMET02995 0.887 0.003 DBMET02996 | DBMET02996 | |
| 0.005 | 0.145 | 0.471 | NMDA receptor glycine site antagonist | 0.471 0.002 DBMET02986 0.031 0.012 DBMET02995 | DBMET02986 | |
| 0.045 | 0.188 | 0.103 | Glycogen synthase kinase-3 inhibitor | 0.103 0.077 DBMET02995 | DBMET02995 | |
| 0.048 | 0.192 | 0.117 | Glycogen synthase kinase-3 alpha inhibitor | 0.117 0.087 DBMET02995 | DBMET02995 | |
| 0.093 | 0.237 | 0.136 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.134 0.107 DBMET02986 0.136 0.102 DBMET02995 | DBMET02995 | |
| 0.007 | 0.154 | 0.029 | Imidazoline I1 receptor antagonist | 0.023 0.012 DBMET02989 0.029 0.007 DBMET02995 | DBMET02995 | |
| 0.011 | 0.159 | 0.422 | NMDA receptor subunit 3A antagonist | 0.422 0.003 DBMET02986 0.102 0.008 DBMET02995 | DBMET02986 | |
| 0.04 | 0.187 | 0.094 | Granulocyte macrophage colony stimulating factor antagonist | 0.094 0.079 DBMET02995 | DBMET02995 | |
| 0.105 | 0.255 | 0.282 | Death-associated protein kinase 2 inhibitor | 0.147 0.114 DBMET02986 0.168 0.07 DBMET02995 0.282 0.008 DBMET02994 | DBMET02994 | |
| 0.026 | 0.178 | 0.081 | Glutamate receptor agonist | 0.081 0.052 DBMET02986 | DBMET02986 | |
| 0.041 | 0.194 | 0.111 | Glycogen synthase kinase-3 beta inhibitor | 0.111 0.067 DBMET02995 | DBMET02995 | |
| 0.014 | 0.168 | 0.049 | Chemokine receptor agonist | 0.049 0.036 DBMET02995 | DBMET02995 | |
| 0.023 | 0.178 | 0.064 | Purinergic P2X4 antagonist | 0.047 0.03 DBMET02986 0.064 0.012 DBMET02995 0.045 0.034 DBMET02991 | DBMET02995 | |
| 0.058 | 0.215 | 0.192 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.192 0.068 DBMET02995 | DBMET02995 | |
| 0.017 | 0.176 | 0.07 | 5 Hydroxytryptamine 4 antagonist | 0.07 0.017 DBMET02995 | DBMET02995 | |
| 0.009 | 0.169 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.022 0.01 DBMET02986 | DBMET02986 | |
| 0.007 | 0.169 | 0.171 | AMPA 3 receptor antagonist | 0.171 0.003 DBMET02986 0.028 0.022 DBMET02995 | DBMET02986 | |
| 0.032 | 0.194 | 0.074 | Corticotropin releasing factor 2 receptor antagonist | 0.067 0.033 DBMET02986 0.074 0.023 DBMET02995 | DBMET02995 | |
| 0.003 | 0.165 | 0.186 | Kainate receptor 1 antagonist | 0.186 0.003 DBMET02986 0.046 0.006 DBMET02995 | DBMET02986 | |
| 0.021 | 0.185 | 0.067 | Histamine agonist | 0.067 0.021 DBMET02995 | DBMET02995 | |
| 0.125 | 0.289 | 0.203 | Neuropeptide Y2 antagonist | 0.203 0.114 DBMET02995 | DBMET02995 | |
| 0.046 | 0.211 | 0.182 | 5 Hydroxytryptamine 3A agonist | 0.182 0.021 DBMET02989 0.175 0.023 DBMET02995 0.139 0.042 DBMET02990 0.139 0.042 DBMET02991 | DBMET02989 | |
| 0.028 | 0.195 | 0.048 | Phosphodiesterase 6C inhibitor | 0.048 0.027 DBMET02992 | DBMET02992 | |
| 0.016 | 0.183 | 0.05 | Neurokinin antagonist | 0.05 0.034 DBMET02994 | DBMET02994 | |
| 0.009 | 0.177 | 0.035 | Nicotinic acid receptor agonist | 0.035 0.027 DBMET02986 0.034 0.028 DBMET02989 | DBMET02986 | |
| 0.028 | 0.2 | 0.109 | 5 Hydroxytryptamine 3 agonist | 0.109 0.012 DBMET02989 0.064 0.043 DBMET02995 0.085 0.023 DBMET02990 0.088 0.022 DBMET02991 | DBMET02989 | |
| 0.003 | 0.178 | 0.24 | AMPA 1 receptor antagonist | 0.24 0.003 DBMET02986 0.03 0.02 DBMET02995 | DBMET02986 | |
| 0.046 | 0.22 | 0.126 | MDM2 inhibitor | 0.126 0.004 DBMET02986 0.109 0.005 DBMET02995 | DBMET02986 | |
| 0.007 | 0.187 | 0.045 | Carnitine palmitoyltransferase 1A inhibitor | 0.045 0.008 DBMET02986 | DBMET02986 | |
| 0.027 | 0.208 | 0.106 | Phospholipase D inhibitor | 0.085 0.027 DBMET02986 0.073 0.046 DBMET02989 0.106 0.012 DBMET02995 | DBMET02995 | |
| 0.098 | 0.284 | 0.175 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.175 0.1 DBMET02995 | DBMET02995 | |
| 0.017 | 0.203 | 0.081 | Potassium channel (Inward rectifier) blocker | 0.073 0.016 DBMET02991 0.081 0.012 DBMET02992 | DBMET02992 | |
| 0.007 | 0.195 | 0.339 | Kainate receptor antagonist | 0.339 0.003 DBMET02986 0.108 0.007 DBMET02995 | DBMET02986 | |
| 0.029 | 0.218 | 0.076 | Analgesic, opioid | 0.076 0.053 DBMET02995 | DBMET02995 | |
| 0.01 | 0.202 | 0.028 | Phosphodiesterase 6B inhibitor | 0.028 0.025 DBMET02992 | DBMET02992 | |
| 0.027 | 0.22 | 0.138 | Cathepsin G inhibitor | 0.135 0.024 DBMET02986 0.064 0.062 DBMET02991 0.138 0.023 DBMET02992 | DBMET02992 | |
| 0.038 | 0.232 | 0.081 | Opioid kappa receptor antagonist | 0.081 0.056 DBMET02995 | DBMET02995 | |
| 0.046 | 0.245 | 0.125 | Proteasome inhibitor | 0.125 0.062 DBMET02989 | DBMET02989 | |
| 0.024 | 0.224 | 0.049 | Dipeptidyl peptidase inhibitor | 0.049 0.045 DBMET02995 | DBMET02995 | |
| 0.02 | 0.221 | 0.068 | CXC chemokine 4 receptor antagonist | 0.068 0.037 DBMET02995 | DBMET02995 | |
| 0.023 | 0.23 | 0.055 | Alpha 1L adrenoreceptor agonist | 0.055 0.011 DBMET02989 0.05 0.017 DBMET02995 0.052 0.014 DBMET02990 0.055 0.011 DBMET02991 0.044 0.027 DBMET02992 | DBMET02991 | |
| 0.052 | 0.26 | 0.087 | Alpha 2d adrenoreceptor antagonist | 0.087 0.079 DBMET02989 | DBMET02989 | |
| 0.035 | 0.245 | 0.128 | Mediator release inhibitor | 0.128 0.041 DBMET02986 0.093 0.078 DBMET02995 | DBMET02986 | |
| 0.033 | 0.244 | 0.09 | Opioid antagonist | 0.09 0.057 DBMET02995 | DBMET02995 | |
| 0.015 | 0.226 | 0.078 | Acetylcholine M5 receptor agonist | 0.071 0.043 DBMET02989 0.078 0.036 DBMET02995 | DBMET02995 | |
| 0.099 | 0.315 | 0.168 | Cyclin-dependent kinase 3 inhibitor | 0.168 0.064 DBMET02996 | DBMET02996 | |
| 0.052 | 0.267 | 0.118 | Nav1.5 sodium channel blocker | 0.118 0.057 DBMET02995 | DBMET02995 | |
| 0.09 | 0.307 | 0.446 | Cyclic AMP phosphodiesterase inhibitor | 0.446 0.011 DBMET02986 0.321 0.034 DBMET02995 | DBMET02986 | |
| 0.041 | 0.258 | 0.125 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.125 0.078 DBMET02995 0.116 0.085 DBMET02994 | DBMET02995 | |
| 0.009 | 0.228 | 0.087 | Phosphodiesterase 3B inhibitor | 0.087 0.014 DBMET02992 | DBMET02992 | |
| 0.016 | 0.236 | 0.092 | Alpha 2 adrenoreceptor agonist | 0.061 0.041 DBMET02989 0.092 0.017 DBMET02995 0.081 0.023 DBMET02991 | DBMET02995 | |
| 0.07 | 0.291 | 0.14 | Death-associated protein kinase 3 inhibitor | 0.14 0.139 DBMET02989 | DBMET02989 | |
| 0.033 | 0.254 | 0.117 | Protein kinase C delta inhibitor | 0.117 0.039 DBMET02989 | DBMET02989 | |
| 0.053 | 0.276 | 0.138 | Toll-Like receptor antagonist | 0.138 0.065 DBMET02989 | DBMET02989 | |
| 0.081 | 0.309 | 0.189 | Neurotrophic factor enhancer | 0.167 0.114 DBMET02986 0.189 0.088 DBMET02995 | DBMET02995 | |
| 0.029 | 0.257 | 0.36 | Bcl2 antagonist | 0.06 0.056 DBMET02984 0.36 0.002 DBMET02996 | DBMET02996 | |
| 0.115 | 0.344 | 0.294 | Insulysin inhibitor | 0.294 0.062 DBMET02986 0.246 0.1 DBMET02989 0.24 0.106 DBMET02992 | DBMET02986 | |
| 0.109 | 0.339 | 0.213 | 15-Lipoxygenase inhibitor | 0.213 0.199 DBMET02986 | DBMET02986 | |
| 0.126 | 0.357 | 0.22 | 5 Hydroxytryptamine 3E antagonist | 0.205 0.055 DBMET02989 0.169 0.139 DBMET02993 0.181 0.103 DBMET02995 0.201 0.06 DBMET02990 0.22 0.037 DBMET02991 0.179 0.109 DBMET02992 | DBMET02991 | |
| 0.006 | 0.238 | 0.038 | Farnesoid X receptor agonist | 0.038 0.025 DBMET02986 | DBMET02986 | |
| 0.004 | 0.237 | 0.022 | Methionyl aminopeptidase 2 inhibitor | 0.022 0.021 DBMET02986 | DBMET02986 | |
| 0.009 | 0.241 | 0.099 | Glutamate (mGluR1) antagonist | 0.099 0.016 DBMET02986 | DBMET02986 | |
| 0.011 | 0.247 | 0.134 | Aldose reductase inhibitor | 0.134 0.012 DBMET02986 | DBMET02986 | |
| 0.023 | 0.263 | 0.311 | NMDA receptor agonist | 0.311 0.003 DBMET02986 | DBMET02986 | |
| 0.046 | 0.288 | 0.156 | Neurotrophic factor | 0.156 0.054 DBMET02995 | DBMET02995 | |
| 0.023 | 0.267 | 0.068 | Beta adrenoreceptor antagonist | 0.068 0.042 DBMET02986 | DBMET02986 | |
| 0.039 | 0.284 | 0.115 | Nav1.6 sodium channel blocker | 0.115 0.103 DBMET02995 | DBMET02995 | |
| 0.008 | 0.258 | 0.022 | Factor XIII inhibitor | 0.022 0.012 DBMET02989 0.021 0.013 DBMET02991 | DBMET02989 | |
| 0.006 | 0.257 | 0.048 | Sphingosine 1-phosphate receptor 1 agonist | 0.048 0.022 DBMET02986 | DBMET02986 | |
| 0.006 | 0.259 | 0.082 | Carnitine palmitoyltransferase 1 inhibitor | 0.082 0.004 DBMET02986 | DBMET02986 | |
| 0.02 | 0.274 | 0.088 | Protein kinase (CK2) inhibitor | 0.088 0.075 DBMET02986 | DBMET02986 | |
| 0.113 | 0.368 | 0.291 | Nitric-oxide synthase stimulant | 0.291 0.014 DBMET02986 0.212 0.071 DBMET02995 | DBMET02986 | |
| 0.038 | 0.294 | 0.112 | DNA directed RNA polymerase inhibitor | 0.112 0.044 DBMET02986 0.086 0.075 DBMET02995 | DBMET02986 | |
| 0.039 | 0.297 | 0.111 | Phosphodiesterase 11A inhibitor | 0.111 0.025 DBMET02992 | DBMET02992 | |
| 0.039 | 0.297 | 0.111 | Phosphodiesterase XI inhibitor | 0.111 0.025 DBMET02992 | DBMET02992 | |
| 0.024 | 0.285 | 0.062 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.062 0.038 DBMET02995 | DBMET02995 | |
| 0.023 | 0.283 | 0.084 | MAP-kinase-activated kinase 2 inhibitor | 0.084 0.04 DBMET02995 0.072 0.055 DBMET02992 | DBMET02995 | |
| 0.075 | 0.339 | 0.17 | Focal adhesion kinase 2 inhibitor | 0.143 0.141 DBMET02986 0.166 0.106 DBMET02995 0.17 0.1 DBMET02991 | DBMET02991 | |
| 0.038 | 0.302 | 0.123 | Caspase 3 inhibitor | 0.123 0.055 DBMET02986 | DBMET02986 | |
| 0.007 | 0.273 | 0.032 | 5 Hydroxytryptamine 6 agonist | 0.029 0.02 DBMET02989 0.028 0.021 DBMET02990 0.032 0.014 DBMET02991 | DBMET02991 | |
| 0.028 | 0.296 | 0.093 | MAP-kinase-activated kinase inhibitor | 0.093 0.045 DBMET02995 0.081 0.06 DBMET02992 | DBMET02995 | |
| 0.006 | 0.275 | 0.082 | Carnitine palmitoyltransferase inhibitor | 0.082 0.004 DBMET02986 | DBMET02986 | |
| 0.055 | 0.325 | 0.412 | Interleukin antagonist | 0.234 0.068 DBMET02986 0.412 0.029 DBMET02994 | DBMET02994 | |
| 0.009 | 0.28 | 0.042 | Factor XIa inhibitor | 0.042 0.026 DBMET02986 | DBMET02986 | |
| 0.006 | 0.277 | 0.056 | Melanin-concentrating hormone receptor 1 antagonist | 0.056 0.033 DBMET02995 | DBMET02995 | |
| 0.005 | 0.277 | 0.041 | Factor XI inhibitor | 0.041 0.015 DBMET02986 | DBMET02986 | |
| 0.079 | 0.351 | 0.127 | Death-associated protein kinase 1 inhibitor | 0.127 0.089 DBMET02995 | DBMET02995 | |
| 0.033 | 0.307 | 0.117 | MAP kinase kinase inhibitor | 0.117 0.076 DBMET02989 | DBMET02989 | |
| 0.011 | 0.287 | 0.188 | NMDA receptor glycine site agonist | 0.188 0.003 DBMET02986 | DBMET02986 | |
| 0.02 | 0.296 | 0.098 | Protein kinase (CK2) alpha inhibitor | 0.098 0.078 DBMET02986 | DBMET02986 | |
| 0.038 | 0.316 | 0.134 | Cytidine deaminase inhibitor | 0.134 0.088 DBMET02989 | DBMET02989 | |
| 0.065 | 0.351 | 0.21 | Beta lactamase inhibitor | 0.197 0.187 DBMET02991 0.21 0.179 DBMET02992 | DBMET02992 | |
| 0.042 | 0.331 | 0.121 | Activin receptor-like kinase 2 inhibitor | 0.117 0.1 DBMET02989 0.121 0.095 DBMET02995 | DBMET02995 | |
| 0.11 | 0.4 | 0.355 | Calcium channel activator | 0.355 0.047 DBMET02986 0.26 0.136 DBMET02989 0.354 0.047 DBMET02995 0.219 0.187 DBMET02990 0.253 0.143 DBMET02994 0.312 0.08 DBMET02991 0.299 0.093 DBMET02992 | DBMET02986 | |
| 0.045 | 0.335 | 0.111 | Acetylcholine release stimulant | 0.111 0.063 DBMET02995 | DBMET02995 | |
| 0.021 | 0.313 | 0.073 | ALK inhibitor | 0.073 0.07 DBMET02995 | DBMET02995 | |
| 0.047 | 0.342 | 0.159 | MAP3K9 inhibitor | 0.159 0.048 DBMET02992 | DBMET02992 | |
| 0.008 | 0.306 | 0.07 | Prostaglandin E2 antagonist | 0.07 0.024 DBMET02986 | DBMET02986 | |
| 0.016 | 0.317 | 0.094 | Carnitine palmitoyltransferase 1B inhibitor | 0.094 0.005 DBMET02986 | DBMET02986 | |
| 0.025 | 0.33 | 0.064 | Beta 3 adrenoreceptor antagonist | 0.064 0.044 DBMET02986 | DBMET02986 | |
| 0.005 | 0.309 | 0.046 | Glutamate (mGluR group II) antagonist | 0.046 0.019 DBMET02986 | DBMET02986 | |
| 0.004 | 0.31 | 0.028 | Thyroid hormone alpha agonist | 0.028 0.004 DBMET02986 | DBMET02986 | |
| 0.05 | 0.356 | 0.133 | Neuropeptide Y1 antagonist | 0.133 0.095 DBMET02995 | DBMET02995 | |
| 0.03 | 0.337 | 0.162 | Toll-Like receptor 9 antagonist | 0.162 0.055 DBMET02989 | DBMET02989 | |
| 0.135 | 0.443 | 0.393 | Calcium channel L-type activator | 0.393 0.086 DBMET02986 0.248 0.207 DBMET02995 0.332 0.131 DBMET02992 | DBMET02986 | |
| 0.009 | 0.318 | 0.056 | Sphingosine 1-phosphate receptor agonist | 0.056 0.02 DBMET02986 | DBMET02986 | |
| 0.004 | 0.313 | 0.053 | Prostaglandin EP3 antagonist | 0.053 0.009 DBMET02986 | DBMET02986 | |
| 0.016 | 0.327 | 0.064 | Potassium channel (ATP-sensitive) activator | 0.044 0.043 DBMET02989 0.064 0.013 DBMET02991 0.053 0.024 DBMET02992 | DBMET02991 | |
| 0.032 | 0.345 | 0.282 | Psychostimulant | 0.215 0.072 DBMET02986 0.282 0.048 DBMET02995 | DBMET02995 | |
| 0.019 | 0.333 | 0.108 | Chemokine receptor antagonist | 0.108 0.056 DBMET02995 | DBMET02995 | |
| 0.01 | 0.324 | 0.07 | Nicotinic receptor alpha7 subunit antagonist | 0.07 0.021 DBMET02989 | DBMET02989 | |
| 0.017 | 0.331 | 0.067 | Potassium channel (Inward rectifier) activator | 0.046 0.044 DBMET02989 0.067 0.013 DBMET02991 0.056 0.025 DBMET02992 | DBMET02991 | |
| 0.016 | 0.332 | 0.036 | Glutamate (mGluR8) antagonist | 0.036 0.024 DBMET02986 | DBMET02986 | |
| 0.026 | 0.345 | 0.12 | Polo-like kinase-1 inhibitor | 0.094 0.055 DBMET02986 0.12 0.03 DBMET02995 | DBMET02995 | |
| 0.007 | 0.326 | 0.044 | Dopamine D5 agonist | 0.044 0.022 DBMET02989 | DBMET02989 | |
| 0.094 | 0.414 | 0.146 | Ca2+-transporting ATPase inhibitor | 0.146 0.054 DBMET02986 0.131 0.117 DBMET02989 0.13 0.121 DBMET02995 | DBMET02986 | |
| 0.017 | 0.345 | 0.118 | Glutamate (mGluR4) antagonist | 0.118 0.004 DBMET02986 | DBMET02986 | |
| 0.034 | 0.363 | 0.212 | Electrolyte absorption antagonist | 0.212 0.007 DBMET02986 0.086 0.082 DBMET02991 | DBMET02986 | |
| 0.007 | 0.337 | 0.047 | Lysophosphatidic acid 2 receptor antagonist | 0.047 0.009 DBMET02986 | DBMET02986 | |
| 0.013 | 0.344 | 0.074 | HIV-1 reverse transcriptase inhibitor | 0.074 0.046 DBMET02986 | DBMET02986 | |
| 0.053 | 0.385 | 0.13 | Antipruritic | 0.13 0.122 DBMET02995 | DBMET02995 | |
| 0.023 | 0.355 | 0.059 | Ca(v)3.2 blocker | 0.056 0.047 DBMET02991 0.059 0.039 DBMET02992 | DBMET02992 | |
| 0.005 | 0.337 | 0.178 | AMPA receptor antagonist | 0.178 0.005 DBMET02986 | DBMET02986 | |
| 0.003 | 0.34 | 0.015 | Nicotinic alpha4 receptor agonist | 0.015 0.014 DBMET02995 | DBMET02995 | |
| 0.021 | 0.364 | 0.076 | Histamine N-methyltransferase inhibitor | 0.076 0.072 DBMET02995 | DBMET02995 | |
| 0.029 | 0.373 | 0.114 | MAP kinase kinase 1 inhibitor | 0.114 0.041 DBMET02989 | DBMET02989 | |
| 0.025 | 0.369 | 0.08 | Histamine H2 receptor antagonist | 0.08 0.066 DBMET02991 | DBMET02991 | |
| 0.014 | 0.359 | 0.073 | Protein kinase C beta inhibitor | 0.073 0.043 DBMET02989 | DBMET02989 | |
| 0.059 | 0.406 | 0.315 | Thyroid hormone beta antagonist | 0.315 0.081 DBMET02986 | DBMET02986 | |
| 0.004 | 0.35 | 0.034 | Kynurenine 3 monooxygenase inhibitor | 0.034 0.013 DBMET02986 | DBMET02986 | |
| 0.014 | 0.362 | 0.088 | Phosphodiesterase III inhibitor | 0.088 0.029 DBMET02992 | DBMET02992 | |
| 0.01 | 0.359 | 0.059 | Neuronal nicotinic receptor antagonist | 0.059 0.056 DBMET02989 | DBMET02989 | |
| 0.003 | 0.354 | 0.024 | VLA-4 antagonist | 0.024 0.019 DBMET02986 | DBMET02986 | |
| 0.015 | 0.366 | 0.063 | Kainate receptor agonist | 0.063 0.006 DBMET02986 | DBMET02986 | |
| 0.012 | 0.364 | 0.06 | Beta 1 adrenoreceptor antagonist | 0.06 0.036 DBMET02986 | DBMET02986 | |
| 0.021 | 0.375 | 0.059 | Beta 2 adrenoreceptor agonist | 0.059 0.053 DBMET02986 | DBMET02986 | |
| 0.08 | 0.434 | 0.384 | 5 Hydroxytryptamine release stimulant | 0.188 0.132 DBMET02986 0.321 0.064 DBMET02989 0.218 0.107 DBMET02995 0.247 0.091 DBMET02990 0.384 0.049 DBMET02991 | DBMET02991 | |
| 0.1 | 0.454 | 0.291 | Tyrosine 3 hydroxylase inhibitor | 0.291 0.038 DBMET02986 0.255 0.063 DBMET02989 0.18 0.177 DBMET02995 0.235 0.084 DBMET02990 0.235 0.084 DBMET02991 0.183 0.169 DBMET02992 | DBMET02986 | |
| 0.022 | 0.377 | 0.161 | Vascular endothelial growth factor antagonist | 0.161 0.051 DBMET02996 | DBMET02996 | |
| 0.015 | 0.373 | 0.155 | Vascular endothelial growth factor 2 antagonist | 0.155 0.048 DBMET02996 | DBMET02996 | |
| 0.013 | 0.374 | 0.049 | Beta 2 adrenoreceptor antagonist | 0.049 0.037 DBMET02986 | DBMET02986 | |
| 0.045 | 0.407 | 0.318 | Aldehyde oxidase inhibitor | 0.23 0.09 DBMET02986 0.201 0.104 DBMET02989 0.169 0.123 DBMET02990 0.318 0.062 DBMET02991 0.168 0.124 DBMET02992 | DBMET02991 | |
| 0.009 | 0.374 | 0.071 | Cyclin-dependent kinase 6 inhibitor | 0.071 0.03 DBMET02989 | DBMET02989 | |
| 0.006 | 0.372 | 0.041 | ATP citrate lysase inhibitor | 0.041 0.012 DBMET02986 | DBMET02986 | |
| 0.026 | 0.392 | 0.158 | Cyclooxygenase 1 inhibitor | 0.158 0.053 DBMET02986 | DBMET02986 | |
| 0.016 | 0.383 | 0.094 | Glutamate (mGluR group III) antagonist | 0.094 0.005 DBMET02986 | DBMET02986 | |
| 0.007 | 0.376 | 0.105 | Glutamate (mGluR3) antagonist | 0.105 0.004 DBMET02986 | DBMET02986 | |
| 0.006 | 0.383 | 0.075 | Prostaglandin EP2 antagonist | 0.075 0.03 DBMET02986 | DBMET02986 | |
| 0.053 | 0.432 | 0.358 | Thyroid hormone antagonist | 0.358 0.071 DBMET02986 | DBMET02986 | |
| 0.054 | 0.439 | 0.143 | MAP kinase 3 inhibitor | 0.143 0.079 DBMET02986 0.134 0.098 DBMET02995 | DBMET02986 | |
| 0.015 | 0.4 | 0.046 | Beta adrenoreceptor agonist | 0.046 0.03 DBMET02986 | DBMET02986 | |
| 0.014 | 0.402 | 0.07 | Cyclin D1 inhibitor | 0.07 0.028 DBMET02995 | DBMET02995 | |
| 0.098 | 0.487 | 0.411 | Interleukin 2 agonist | 0.411 0.024 DBMET02986 | DBMET02986 | |
| 0.025 | 0.414 | 0.092 | Beta glucuronidase inhibitor | 0.09 0.089 DBMET02986 0.092 0.084 DBMET02991 | DBMET02991 | |
| 0.004 | 0.394 | 0.133 | GP IIb/IIIa receptor antagonist | 0.133 0.013 DBMET02993 0.115 0.015 DBMET02994 | DBMET02993 | |
| 0.085 | 0.476 | 0.349 | GABA C receptor rho-3 antagonist | 0.303 0.114 DBMET02986 0.349 0.086 DBMET02989 0.247 0.157 DBMET02995 0.274 0.134 DBMET02990 0.274 0.134 DBMET02991 0.214 0.191 DBMET02992 | DBMET02989 | |
| 0.004 | 0.396 | 0.203 | Factor X inhibitor | 0.203 0.005 DBMET02993 0.185 0.006 DBMET02994 | DBMET02993 | |
| 0.02 | 0.414 | 0.168 | Protein kinase C mu inhibitor | 0.132 0.035 DBMET02989 0.103 0.055 DBMET02990 0.116 0.044 DBMET02991 0.168 0.019 DBMET02992 | DBMET02992 | |
| 0.021 | 0.416 | 0.101 | Protein kinase C gamma inhibitor | 0.101 0.076 DBMET02995 | DBMET02995 | |
| 0.041 | 0.438 | 0.109 | Histone deacetylase SIRT1 inhibitor | 0.109 0.106 DBMET02986 | DBMET02986 | |
| 0.025 | 0.426 | 0.103 | GABA B receptor agonist | 0.103 0.014 DBMET02986 | DBMET02986 | |
| 0.032 | 0.438 | 0.102 | Lanosterol 14 alpha demethylase inhibitor | 0.102 0.053 DBMET02986 | DBMET02986 | |
| 0.019 | 0.427 | 0.076 | Sphingosine 1-phosphate receptor antagonist | 0.076 0.054 DBMET02986 | DBMET02986 | |
| 0.004 | 0.417 | 0.029 | Myristoyl transferase inhibitor | 0.029 0.015 DBMET02990 0.029 0.016 DBMET02991 | DBMET02991 | |
| 0.023 | 0.439 | 0.072 | Viral attachment inhibitor | 0.072 0.069 DBMET02994 | DBMET02994 | |
| 0.023 | 0.439 | 0.063 | Exportin-1 inhibitor | 0.063 0.062 DBMET02995 | DBMET02995 | |
| 0.006 | 0.436 | 0.101 | Prostaglandin-E synthase inhibitor | 0.101 0.027 DBMET02986 | DBMET02986 | |
| 0.099 | 0.53 | 0.487 | 5 Hydroxytryptamine release inhibitor | 0.487 0.037 DBMET02986 0.306 0.159 DBMET02995 | DBMET02986 | |
| 0.03 | 0.461 | 0.203 | DOPA decarboxylase inhibitor | 0.203 0.006 DBMET02986 | DBMET02986 | |
| 0.054 | 0.486 | 0.186 | Hypoxia-inducible factor 1 alpha inhibitor | 0.186 0.17 DBMET02995 | DBMET02995 | |
| 0.033 | 0.465 | 0.555 | Platelet antagonist | 0.319 0.047 DBMET02986 0.555 0.009 DBMET02993 0.542 0.01 DBMET02994 | DBMET02993 | |
| 0.005 | 0.438 | 0.022 | Alpha 1a adrenoreceptor agonist | 0.022 0.016 DBMET02989 | DBMET02989 | |
| 0.02 | 0.453 | 0.058 | Trypsin inhibitor | 0.058 0.052 DBMET02993 | DBMET02993 | |
| 0.003 | 0.436 | 0.051 | Progesterone antagonist | 0.051 0.018 DBMET02986 | DBMET02986 | |
| 0.005 | 0.444 | 0.441 | Prostaglandin antagonist | 0.441 0.004 DBMET02986 | DBMET02986 | |
| 0.008 | 0.449 | 0.105 | Nicotinic alpha4beta2 receptor antagonist | 0.105 0.027 DBMET02995 | DBMET02995 | |
| 0.026 | 0.468 | 0.453 | Anticoagulant | 0.144 0.085 DBMET02986 0.453 0.013 DBMET02993 0.439 0.014 DBMET02994 | DBMET02993 | |
| 0.01 | 0.453 | 0.089 | Pim-3 kinase inhibitor | 0.089 0.06 DBMET02989 | DBMET02989 | |
| 0.027 | 0.472 | 0.137 | Mannose-6-phosphate isomerase inhibitor | 0.137 0.077 DBMET02989 | DBMET02989 | |
| 0.03 | 0.477 | 0.095 | Vanilloid agonist | 0.095 0.039 DBMET02986 | DBMET02986 | |
| 0.009 | 0.456 | 0.046 | Tryptophan 5 hydroxylase inhibitor | 0.046 0.007 DBMET02986 | DBMET02986 | |
| 0.009 | 0.458 | 0.164 | Sphingosine 1-phosphate receptor 4 agonist | 0.164 0.006 DBMET02986 | DBMET02986 | |
| 0.098 | 0.55 | 0.334 | 5 Hydroxytryptamine uptake stimulant | 0.278 0.058 DBMET02986 0.234 0.099 DBMET02989 0.224 0.111 DBMET02995 0.214 0.126 DBMET02990 0.334 0.031 DBMET02991 0.211 0.132 DBMET02992 | DBMET02991 | |
| 0.021 | 0.475 | 0.081 | DNA helicase inhibitor | 0.081 0.01 DBMET02986 | DBMET02986 | |
| 0.065 | 0.52 | 0.215 | RNA-directed DNA polymerase inhibitor | 0.215 0.08 DBMET02986 | DBMET02986 | |
| 0.024 | 0.479 | 0.29 | MAP kinase 13 inhibitor | 0.29 0.006 DBMET02994 | DBMET02994 | |
| 0.096 | 0.551 | 0.316 | Caspase 9 stimulant | 0.284 0.212 DBMET02986 0.316 0.177 DBMET02989 0.284 0.211 DBMET02995 | DBMET02989 | |
| 0.004 | 0.46 | 0.132 | Phosphorylase inhibitor | 0.132 0.009 DBMET02986 | DBMET02986 | |
| 0.03 | 0.487 | 0.107 | Interleukin 5 antagonist | 0.107 0.034 DBMET02986 | DBMET02986 | |
| 0.023 | 0.482 | 0.178 | HIV-1 integrase (Overall Integration) inhibitor | 0.178 0.017 DBMET02986 | DBMET02986 | |
| 0.006 | 0.467 | 0.038 | Liver X receptor alpha antagonist | 0.038 0.01 DBMET02986 | DBMET02986 | |
| 0.018 | 0.482 | 0.273 | Ferrochelatase inhibitor | 0.273 0.01 DBMET02986 | DBMET02986 | |
| 0.053 | 0.516 | 0.891 | Antiobesity | 0.636 0.016 DBMET02984 0.273 0.137 DBMET02986 0.235 0.172 DBMET02995 0.891 0.005 DBMET02990 | DBMET02990 | |
| 0.036 | 0.499 | 0.194 | Vasodilator | 0.194 0.11 DBMET02994 | DBMET02994 | |
| 0.02 | 0.486 | 0.121 | Potassium channel large-conductance Ca-activated activator | 0.121 0.016 DBMET02986 | DBMET02986 | |
| 0.026 | 0.494 | 0.116 | NADH dehydrogenase inhibitor | 0.116 0.031 DBMET02986 | DBMET02986 | |
| 0.042 | 0.51 | 0.276 | ATPase inhibitor | 0.276 0.009 DBMET02986 0.149 0.103 DBMET02995 | DBMET02986 | |
| 0.022 | 0.491 | 0.29 | MAP kinase 12 inhibitor | 0.29 0.007 DBMET02994 | DBMET02994 | |
| 0.017 | 0.488 | 0.278 | Anesthetic general | 0.278 0.039 DBMET02986 0.134 0.132 DBMET02993 0.193 0.078 DBMET02995 | DBMET02986 | |
| 0.058 | 0.53 | 0.208 | Lipocortins synthesis antagonist | 0.208 0.052 DBMET02986 | DBMET02986 | |
| 0.06 | 0.538 | 0.213 | Vasodilator, coronary | 0.213 0.17 DBMET02995 | DBMET02995 | |
| 0.007 | 0.486 | 0.059 | GABA B receptor antagonist | 0.059 0.013 DBMET02986 | DBMET02986 | |
| 0.025 | 0.504 | 0.173 | Interleukin 8 antagonist | 0.173 0.022 DBMET02986 | DBMET02986 | |
| 0.002 | 0.481 | 0.015 | 5-Alpha-reductase 1 inhibitor | 0.015 0.013 DBMET02986 | DBMET02986 | |
| 0.01 | 0.492 | 0.065 | Sphingosine 1-phosphate receptor 5 agonist | 0.065 0.02 DBMET02986 | DBMET02986 | |
| 0.004 | 0.494 | 0.042 | Liver X receptor beta agonist | 0.042 0.014 DBMET02986 | DBMET02986 | |
| 0.028 | 0.519 | 0.474 | Platelet aggregation inhibitor | 0.191 0.088 DBMET02986 0.474 0.011 DBMET02993 0.425 0.016 DBMET02994 | DBMET02993 | |
| 0.003 | 0.495 | 0.036 | HCV NS5B polymerase inhibitor | 0.028 0.026 DBMET02991 0.036 0.017 DBMET02992 | DBMET02992 | |
| 0.024 | 0.516 | 0.205 | EphB2 antagonist | 0.205 0.084 DBMET02994 | DBMET02994 | |
| 0.016 | 0.508 | 0.111 | Cyclooxygenase 2 inhibitor | 0.111 0.091 DBMET02986 | DBMET02986 | |
| 0.035 | 0.529 | 0.14 | GABA C receptor rho-2 antagonist | 0.14 0.088 DBMET02986 0.13 0.106 DBMET02989 | DBMET02986 | |
| 0.007 | 0.501 | 0.067 | Carbamoyl phosphate synthetase inhibitor | 0.067 0.037 DBMET02986 | DBMET02986 | |
| 0.036 | 0.533 | 0.146 | Adenylate cyclase stimulant | 0.146 0.07 DBMET02986 | DBMET02986 | |
| 0.015 | 0.513 | 0.119 | Cell adhesion molecule inhibitor | 0.119 0.024 DBMET02986 | DBMET02986 | |
| 0.003 | 0.503 | 0.292 | Prostaglandin D2 antagonist | 0.292 0.004 DBMET02986 | DBMET02986 | |
| 0.006 | 0.506 | 0.091 | Androgen agonist | 0.091 0.018 DBMET02986 | DBMET02986 | |
| 0.014 | 0.514 | 0.229 | Diuretic | 0.229 0.035 DBMET02986 | DBMET02986 | |
| 0.005 | 0.51 | 0.573 | Cyclin E1 inhibitor | 0.573 0.003 DBMET02996 | DBMET02996 | |
| 0.043 | 0.549 | 0.307 | Antithrombotic | 0.307 0.083 DBMET02986 | DBMET02986 | |
| 0.056 | 0.563 | 0.321 | Vasodilator, peripheral | 0.321 0.087 DBMET02986 0.278 0.109 DBMET02995 | DBMET02986 | |
| 0.004 | 0.513 | 0.053 | Integrin antagonist | 0.053 0.026 DBMET02986 | DBMET02986 | |
| 0.004 | 0.516 | 0.506 | Cyclin E inhibitor | 0.506 0.003 DBMET02996 | DBMET02996 | |
| 0.023 | 0.538 | 0.082 | MAP kinase kinase 7 inhibitor | 0.082 0.04 DBMET02989 0.074 0.064 DBMET02990 0.076 0.058 DBMET02991 | DBMET02989 | |
| 0.019 | 0.535 | 0.14 | Cyclooxygenase inhibitor | 0.14 0.079 DBMET02986 | DBMET02986 | |
| 0.004 | 0.521 | 0.044 | Factor Xa inhibitor | 0.044 0.034 DBMET02993 | DBMET02993 | |
| 0.003 | 0.521 | 0.026 | Prostaglandin EP4 antagonist | 0.026 0.019 DBMET02986 | DBMET02986 | |
| 0.025 | 0.546 | 0.105 | TRPA1 agonist | 0.105 0.08 DBMET02986 | DBMET02986 | |
| 0.01 | 0.535 | 0.154 | MAP kinase 11 inhibitor | 0.154 0.017 DBMET02994 | DBMET02994 | |
| 0.013 | 0.542 | 0.081 | Potassium channel activator | 0.079 0.078 DBMET02991 0.081 0.074 DBMET02992 | DBMET02992 | |
| 0.014 | 0.546 | 0.055 | Dihydroorotate oxidase inhibitor | 0.055 0.039 DBMET02986 | DBMET02986 | |
| 0.004 | 0.536 | 0.045 | Liver X receptor beta antagonist | 0.045 0.01 DBMET02986 | DBMET02986 | |
| 0.005 | 0.54 | 0.03 | Integrin alpha2beta1 antagonist | 0.03 0.013 DBMET02986 | DBMET02986 | |
| 0.012 | 0.548 | 0.096 | Cholesterol synthesis inhibitor | 0.096 0.093 DBMET02986 | DBMET02986 | |
| 0.005 | 0.543 | 0.036 | Liver X receptor antagonist | 0.036 0.017 DBMET02986 | DBMET02986 | |
| 0.015 | 0.555 | 0.338 | GABA C receptor agonist | 0.338 0.007 DBMET02986 0.132 0.042 DBMET02989 0.101 0.065 DBMET02990 0.101 0.065 DBMET02991 | DBMET02986 | |
| 0.005 | 0.548 | 0.071 | Phosphodiesterase 4D inhibitor | 0.071 0.054 DBMET02986 | DBMET02986 | |
| 0.003 | 0.547 | 0.018 | 5-Alpha-reductase 2 inhibitor | 0.018 0.015 DBMET02986 | DBMET02986 | |
| 0.02 | 0.565 | 0.055 | Alpha 1b adrenoreceptor agonist | 0.049 0.037 DBMET02989 0.048 0.039 DBMET02990 0.055 0.026 DBMET02991 | DBMET02991 | |
| 0.011 | 0.559 | 0.06 | Pregnane X receptor antagonist | 0.06 0.031 DBMET02986 | DBMET02986 | |
| 0.033 | 0.583 | 0.291 | Interleukin agonist | 0.291 0.052 DBMET02986 | DBMET02986 | |
| 0.025 | 0.583 | 0.134 | Pregnane X receptor agonist | 0.134 0.089 DBMET02986 | DBMET02986 | |
| 0.043 | 0.602 | 0.472 | Histamine release inhibitor | 0.472 0.04 DBMET02986 | DBMET02986 | |
| 0.005 | 0.567 | 0.073 | Biliverdin reductase inhibitor | 0.073 0.03 DBMET02986 | DBMET02986 | |
| 0.014 | 0.578 | 0.097 | Interleukin 1 beta converting enzyme inhibitor | 0.097 0.062 DBMET02986 | DBMET02986 | |
| 0.004 | 0.571 | 0.039 | RNA-directed RNA polymerase inhibitor | 0.035 0.023 DBMET02991 0.039 0.019 DBMET02992 | DBMET02992 | |
| 0.007 | 0.578 | 0.103 | Androgen antagonist | 0.103 0.044 DBMET02986 | DBMET02986 | |
| 0.006 | 0.578 | 0.064 | Thromboxane synthase inhibitor | 0.064 0.022 DBMET02986 | DBMET02986 | |
| 0.02 | 0.596 | 0.184 | Cell adhesion inhibitor | 0.184 0.029 DBMET02986 | DBMET02986 | |
| 0.001 | 0.578 | 0.022 | Thyroid hormone beta agonist | 0.022 0.003 DBMET02986 | DBMET02986 | |
| 0.002 | 0.581 | 0.047 | 5-Alpha-reductase inhibitor | 0.047 0.02 DBMET02986 | DBMET02986 | |
| 0.004 | 0.585 | 0.064 | Liver X receptor alpha agonist | 0.064 0.011 DBMET02986 | DBMET02986 | |
| 0.014 | 0.595 | 0.213 | Potassium channel (Ca-activated) activator | 0.213 0.012 DBMET02986 | DBMET02986 | |
| 0.012 | 0.595 | 0.172 | GABA C receptor antagonist | 0.172 0.02 DBMET02986 0.097 0.083 DBMET02989 | DBMET02986 | |
| 0.015 | 0.599 | 0.13 | GABA C receptor rho-1 antagonist | 0.13 0.032 DBMET02986 0.096 0.068 DBMET02989 | DBMET02986 | |
| 0.004 | 0.588 | 0.057 | Thymidylate synthase inhibitor | 0.057 0.02 DBMET02986 | DBMET02986 | |
| 0.011 | 0.596 | 0.064 | Glucosylceramidase inhibitor | 0.056 0.036 DBMET02989 0.051 0.046 DBMET02990 0.064 0.026 DBMET02991 | DBMET02991 | |
| 0.017 | 0.604 | 0.089 | Chymotrypsin inhibitor | 0.089 0.044 DBMET02992 | DBMET02992 | |
| 0.006 | 0.596 | 0.041 | Integrin alpha2 antagonist | 0.041 0.02 DBMET02986 | DBMET02986 | |
| 0.036 | 0.632 | 0.292 | Gastrin inhibitor | 0.292 0.038 DBMET02986 | DBMET02986 | |
| 0.019 | 0.615 | 0.164 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.164 0.023 DBMET02986 | DBMET02986 | |
| 0.005 | 0.602 | 0.04 | Liver X receptor agonist | 0.04 0.036 DBMET02986 | DBMET02986 | |
| 0.032 | 0.629 | 0.148 | Vanilloid 1 agonist | 0.148 0.04 DBMET02986 | DBMET02986 | |
| 0.017 | 0.619 | 0.14 | Bile acid receptor antagonist | 0.14 0.009 DBMET02986 | DBMET02986 | |
| 0.019 | 0.623 | 0.121 | Aldehyde dehydrogenase inhibitor | 0.121 0.07 DBMET02986 | DBMET02986 | |
| 0.013 | 0.622 | 0.09 | UDP-glucose 4-epimerase inhibitor | 0.09 0.074 DBMET02986 | DBMET02986 | |
| 0.003 | 0.618 | 0.066 | Thyroid hormone agonist | 0.066 0.004 DBMET02986 | DBMET02986 | |
| 0.019 | 0.634 | 0.119 | Sphingosine 1-phosphate receptor 4 antagonist | 0.119 0.073 DBMET02986 | DBMET02986 | |
| 0.02 | 0.635 | 0.224 | Succinate dehydrogenase inhibitor | 0.224 0.033 DBMET02986 | DBMET02986 | |
| 0.034 | 0.652 | 0.198 | Superoxide dismutase inhibitor | 0.198 0.119 DBMET02989 0.17 0.156 DBMET02990 0.17 0.156 DBMET02991 | DBMET02989 | |
| 0.037 | 0.663 | 0.266 | Immunomodulator | 0.266 0.103 DBMET02986 | DBMET02986 | |
| 0.014 | 0.641 | 0.221 | Calpain inhibitor | 0.221 0.094 DBMET02991 0.176 0.14 DBMET02992 | DBMET02991 | |
| 0.01 | 0.64 | 0.124 | Cystathionine beta-synthase inhibitor | 0.124 0.055 DBMET02986 | DBMET02986 | |
| 0.004 | 0.635 | 0.038 | Leukotriene C4 antagonist | 0.038 0.029 DBMET02986 | DBMET02986 | |
| 0.006 | 0.641 | 0.059 | Leukotriene C antagonist | 0.059 0.031 DBMET02986 | DBMET02986 | |
| 0.003 | 0.639 | 0.049 | Alpha 1d adrenoreceptor agonist | 0.049 0.017 DBMET02989 0.038 0.028 DBMET02990 0.041 0.024 DBMET02991 | DBMET02989 | |
| 0.021 | 0.661 | 0.117 | Photosensitizer | 0.117 0.061 DBMET02986 | DBMET02986 | |
| 0.006 | 0.647 | 0.068 | HIV-1 integrase inhibitor | 0.068 0.052 DBMET02986 | DBMET02986 | |
| 0.005 | 0.651 | 0.065 | Phenylalanine 4-hydroxylase inhibitor | 0.065 0.051 DBMET02986 | DBMET02986 | |
| 0.023 | 0.674 | 0.089 | Glutamate (mGluR7) agonist | 0.089 0.086 DBMET02986 | DBMET02986 | |
| 0.031 | 0.682 | 0.165 | Neurotensin receptor agonist | 0.165 0.07 DBMET02986 | DBMET02986 | |
| 0.007 | 0.664 | 0.077 | GABA aminotransferase inhibitor | 0.077 0.051 DBMET02986 | DBMET02986 | |
| 0.014 | 0.672 | 0.071 | Glutamate (mGluR6) antagonist | 0.071 0.039 DBMET02986 | DBMET02986 | |
| 0.005 | 0.664 | 0.134 | Catalase inhibitor | 0.134 0.03 DBMET02986 | DBMET02986 | |
| 0.015 | 0.677 | 0.103 | Triose-phosphate isomerase inhibitor | 0.103 0.045 DBMET02986 | DBMET02986 | |
| 0.045 | 0.716 | 0.161 | Catenin beta inhibitor | 0.161 0.082 DBMET02986 | DBMET02986 | |
| 0.006 | 0.68 | 0.112 | Alcohol dehydrogenase inhibitor | 0.112 0.041 DBMET02986 | DBMET02986 | |
| 0.019 | 0.694 | 0.17 | Peroxidase inhibitor | 0.17 0.069 DBMET02986 | DBMET02986 | |
| 0.003 | 0.679 | 0.054 | Argininosuccinate synthase inhibitor | 0.054 0.042 DBMET02986 | DBMET02986 | |
| 0.013 | 0.693 | 0.092 | Anabolic | 0.092 0.076 DBMET02986 | DBMET02986 | |
| 0.011 | 0.695 | 0.193 | Alpha-N-acetylglucosaminidase inhibitor | 0.193 0.036 DBMET02986 0.109 0.089 DBMET02989 | DBMET02986 | |
| 0.024 | 0.71 | 0.131 | Adenylate kinase inhibitor | 0.131 0.035 DBMET02986 | DBMET02986 | |
| 0.012 | 0.7 | 0.1 | Aminopeptidase B inhibitor | 0.1 0.065 DBMET02986 | DBMET02986 | |
| 0.004 | 0.692 | 0.07 | Porphobilinogen synthase inhibitor | 0.07 0.056 DBMET02986 | DBMET02986 | |
| 0.018 | 0.706 | 0.154 | Sphingosine 1-phosphate receptor 5 antagonist | 0.154 0.055 DBMET02986 | DBMET02986 | |
| 0.003 | 0.699 | 0.025 | Thyroid hormone alpha antagonist | 0.025 0.005 DBMET02986 | DBMET02986 | |
| 0.021 | 0.729 | 0.249 | Cholesterol antagonist | 0.249 0.126 DBMET02986 | DBMET02986 | |
| 0.013 | 0.728 | 0.194 | DNA synthesis inhibitor | 0.194 0.133 DBMET02986 0.188 0.142 DBMET02989 | DBMET02986 | |
| 0.021 | 0.744 | 0.168 | Interferon gamma antagonist | 0.168 0.059 DBMET02986 | DBMET02986 | |
| 0.006 | 0.732 | 0.066 | CDC25A inhibitor | 0.066 0.063 DBMET02986 | DBMET02986 | |
| 0.004 | 0.737 | 0.127 | Histidine decarboxylase inhibitor | 0.127 0.024 DBMET02986 | DBMET02986 | |
| 0.004 | 0.74 | 0.044 | Peroxisome proliferator-activated receptor delta antagonist | 0.044 0.012 DBMET02986 | DBMET02986 | |
| 0.005 | 0.743 | 0.059 | Heparanase inhibitor | 0.059 0.025 DBMET02986 | DBMET02986 | |
| 0.004 | 0.742 | 0.091 | Glutamate decarboxylase inhibitor | 0.091 0.035 DBMET02986 | DBMET02986 | |
| 0.003 | 0.742 | 0.035 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.035 0.015 DBMET02986 | DBMET02986 | |
| 0.01 | 0.754 | 0.067 | Glutamate dehydrogenase inhibitor | 0.067 0.061 DBMET02986 | DBMET02986 | |
| 0.004 | 0.76 | 0.054 | Diacylglycerol O-acyltransferase inhibitor | 0.054 0.031 DBMET02986 | DBMET02986 | |
| 0.012 | 0.772 | 0.143 | Hemostatic | 0.143 0.077 DBMET02986 | DBMET02986 | |
| 0.016 | 0.782 | 0.374 | Toll-Like receptor 7 agonist | 0.374 0.071 DBMET02986 | DBMET02986 | |
| 0.007 | 0.773 | 0.188 | Arachidonic acid antagonist | 0.188 0.045 DBMET02986 | DBMET02986 | |
| 0.004 | 0.776 | 0.089 | Peroxisome proliferator-activated receptor gamma agonist | 0.089 0.034 DBMET02986 | DBMET02986 | |
| 0.005 | 0.779 | 0.118 | Sphingosine 1-phosphate receptor 2 antagonist | 0.118 0.101 DBMET02986 | DBMET02986 | |
| 0.015 | 0.789 | 0.377 | Toll-Like receptor agonist | 0.377 0.07 DBMET02986 | DBMET02986 | |
| 0.008 | 0.783 | 0.198 | Immunostimulant | 0.198 0.122 DBMET02986 | DBMET02986 | |
| 0.002 | 0.779 | 0.384 | Free fatty acid receptor 1 agonist | 0.059 0.004 DBMET02984 0.384 0.003 DBMET02990 | DBMET02990 | |
| 0.011 | 0.793 | 0.371 | Interleukin 6 antagonist | 0.153 0.084 DBMET02986 0.371 0.009 DBMET02994 | DBMET02994 | |
| 0.018 | 0.809 | 0.875 | Cyclophilin D inhibitor | 0.656 0.019 DBMET02984 0.481 0.056 DBMET02986 0.875 0.005 DBMET02990 | DBMET02990 | |
| 0.005 | 0.806 | 0.154 | Insulin sensitizer | 0.154 0.127 DBMET02986 | DBMET02986 | |
| 0.014 | 0.818 | 0.094 | Nav1.4 sodium channel blocker | 0.094 0.086 DBMET02992 | DBMET02992 | |
| 0.012 | 0.826 | 0.132 | Cyclooxygenase 3 inhibitor | 0.132 0.065 DBMET02986 | DBMET02986 | |
| 0.018 | 0.836 | 0.313 | Antiinflammatory | 0.313 0.204 DBMET02986 | DBMET02986 | |
| 0.003 | 0.832 | 0.07 | Peroxisome proliferator-activated receptor gamma antagonist | 0.07 0.052 DBMET02986 | DBMET02986 | |
| 0.006 | 0.837 | 0.207 | Non-steroidal antiinflammatory agent | 0.207 0.065 DBMET02986 | DBMET02986 | |
| 0.009 | 0.85 | 0.153 | Insulin secretagoues | 0.153 0.071 DBMET02986 | DBMET02986 | |
| 0.013 | 0.864 | 0.26 | Hypoglycemic | 0.168 0.15 DBMET02986 0.26 0.071 DBMET02990 | DBMET02990 | |
| 0.005 | 0.885 | 0.156 | Hypolipemic | 0.156 0.131 DBMET02986 | DBMET02986 | |
| 0.016 | 0.911 | 0.111 | ABCA1 expression enhancer | 0.111 0.038 DBMET02986 | DBMET02986 | |
| 0.02 | 0.939 | 0.312 | Sodium/bile acid cotransporter inhibitor | 0.312 0.069 DBMET02986 | DBMET02986 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |